INS and diabetes mellitus: Although EA had a hypoglycemic effect in experimental diabetes models by increasing insulin secretion via release of β-endorphins from multiple sources or enhancing insulin activity, little evidence and a lack of randomized control trials observing the clinical applications of EA to improve insulin activity in humans have been seen.